Recombinant Antibodies

Rational Design

Reading Nucleic Acids

Diverse Architectures. Atomic Precision.

Guided by high-resolution structures and computational modeling, we understand how our antibodies function at the atomic level and the molecular logic governing their interactions with DNA and RNA. This allows us to create modification specific binders in a variety of designs best suited for an application.

Cymba-X-antibodies-img-5b

Cymba-X-antibodies-img-6a

Cymba-X-antibodies-img-7a

Cymba-X-dna-rna-technology-img-3a

Cymba-X-antibodies-img-8a

Rationally Engineered. Biochemically Characterized.

We strive to maintain high standards of purity, reproducibility, and functional activity for our antibodies. This is enabled by the recombinant production of monoclonal antibodies that have been rationally engineered and biochemically characterized for optimal affinity and specificity to their nucleic acid target. Our designs are meticulously tested to determine their molecular fingerprint across a suite of diverse DNA and RNA antigens to enhance performance and minimize cross reactivity.

Cymba Antibody Portfolio

Cymba-X-antibodies-img-1a

CYM-1901

Target: Undisclosed

In process

Cymba-X-antibodies-img-2a

CYM-1902

Target: Undisclosed

In process

Cymba-X-antibodies-img-3a

CYM-1903

Target: Undisclosed

In process

Cymba-X-antibodies-img-4a

CYM-1904

Target: Undisclosed

In process